Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Przemyslaw, Rys"'
Publikováno v:
European Journal of Endocrinology. 178:545-563
Background Randomised controlled trials (RCTs) have shown an advantage of continuous subcutaneous insulin infusion (CSII) over multiple daily injections (MDI) in the general type 1 diabetes mellitus (T1DM) population. RCT data on T1DM management in p
Autor:
Sebastian Borys, Aleksandra Zapala, Agnieszka H. Ludwig-Slomczynska, Magdalena Monica, Przemysław Witek, Beata Kieć-Wilk, Przemyslaw Rys, Claudia Frankfurter, Jerzy Hohendorff, Maciej T. Malecki
Negative-pressure wound therapy (NPWT) is an adjunct modality in diabetic foot ulcerations (DFUs). Randomized controlled trials (RCTs) have shown its advantage over standard approaches; however, data from observational studies remain scarce.We perfor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bde43362c7f15a663dc04e1f7df482bd
https://ruj.uj.edu.pl/xmlui/handle/item/257069
https://ruj.uj.edu.pl/xmlui/handle/item/257069
Autor:
Przemyslaw, Rys, Sebastian, Borys, Jerzy, Hohendorff, Aleksandra, Zapala, Przemyslaw, Witek, Magdalena, Monica, Claudia, Frankfurter, Agnieszka, Ludwig-Slomczynska, Beata, Kiec-Wilk, Maciej T, Malecki
Publikováno v:
Endocrine. 68(1)
Negative-pressure wound therapy (NPWT) is an adjunct modality in diabetic foot ulcerations (DFUs). Randomized controlled trials (RCTs) have shown its advantage over standard approaches; however, data from observational studies remain scarce.We perfor
Publikováno v:
Allergy and asthma proceedings. 37(1)
BACKGROUND Inhaled corticosteroids used for treating persistent asthma can suppress adrenal cortisol secretion. This inhibition of endogenous cortisol secretion is an important marker of systemic steroid activity. Although meta-analyses have demonstr
Publikováno v:
The Review of Diabetic Studies. 5:128-135
In this paper, we examine the concept of surrogate endpoints (i.e. substitute outcome measures) and review their use in clinical trials involving therapies for diabetes mellitus using the example of metformin. Trials such as DCCT and UKPDS, in which
Autor:
Grzegorz Niesyczyński, Joanna Lis, Przemyslaw Rys, Albert Syta, Piotr Wojciechowski, Agnieszka Rogoz-Sitek, Maciej T. Malecki
Publikováno v:
Acta Diabetologica
Aims A variety of basal insulin preparations are used to treat patients with type 2 diabetes mellitus (T2DM). We aimed to summarize scientific evidence on relative efficacy and safety of insulin glargine (IGlar) and other insulins in T2DM. Methods A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15f24eb8d4fcf00915c3e0e690a478f6
https://ruj.uj.edu.pl/xmlui/handle/item/93779
https://ruj.uj.edu.pl/xmlui/handle/item/93779